AOCI at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed November 7, 2024, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s AOCI?
- OnKure Therapeutics, Inc. (OKUR) reported AOCI of $2K in Q3 2024.
- How has OnKure Therapeutics, Inc.'s AOCI changed year-over-year?
- OnKure Therapeutics, Inc.'s AOCI increased by 109.5% year-over-year, from -$21K to $2K.
- What is the long-term trend for OnKure Therapeutics, Inc.'s AOCI?
- Over 2 years (2021 to 2023), OnKure Therapeutics, Inc.'s AOCI has grown at a -51.5% compound annual growth rate (CAGR), from $34K to $8K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.